凡利亚药品国际(VRX)

23.40 0.00 0.0%

今开：0.0昨收：23.4
最高：0.0 最低：0.0
涨停价：0.0跌停价：0.0
总市值：8.173601444E9

凡利亚药品国际的最新讨论

民间最牛股神2017-01-10 17:23

$凡利亚药品国际(VRX)$终于recover啦，最近改买期权了，加大杠杆查看全文

徐繁阳2017-01-10 17:21

$欧莱雅(LRLCY)$ 把$凡利亚药品国际(VRX)$ 的Cerave买走了，13亿美元。查看全文

文森特逗2017-01-10 16:14

$凡利亚药品国际(VRX)$ 欧莱雅13亿刀收购vrx三个皮肤药品牌，这是要连环暴击呀[鼓鼓掌]。现在看没有把salix卖给武田反而是好事了。papa棒棒哒！
PARIS, Jan 10 (Reuters) - French cosmetics group L'Oreal said on Tuesday it was buying three skincare brands - CeraVe, AcneFree and A...查看全文

lixj20022017-01-10 14:43

$凡利亚药品国际(VRX)$ $猎豹移动(CMCM)$ 全仓这两股票以后，好久没看股票了，天天有推送消息说美股创新高，今天过来一看，VRX 30+的成本， 猎豹13左右的成本。 现在都成这样了，我也是醉了。。查看全文

Victor_向死而生2017-01-10 12:52

$凡利亚药品国际(VRX)$ 以8.2亿美金向中国的Sanpower出售Dendreon业务，该业务两年前以4亿美金购得。
Valeant sells Dendreon for $819.9M
The buyer in the all-cash deal is China's Sanpower Group.
Proceeds will be used to pay down the company's term debt under its ...查看全文

chen13182017-01-10 12:39

$凡利亚药品国际(VRX)$ 终于等到了好消息！看看明天市场啥反应 [笑]查看全文

钱真理2017-01-10 12:27

$凡利亚药品国际(VRX)$ 终于确定性的卖资产了，终于来了一个确定的买点！
LAVAL, Quebec, Jan. 9, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant" or the "Company") today announced that its affiliate has entered into a ...查看全文

徐繁阳2017-01-10 12:03

$宏图高科(SH600122)$ 的母公司三胞集团也真牛逼，8.19亿美元问$凡利亚药品国际(VRX)$ 买了Dendreon制药。Dendreon是生产前列腺癌疫苗的。[想一下] 难道这东西要在中国上市？查看全文

chen13182017-01-04 21:28

$凡利亚药品国际(VRX)$ 投行分析师又出来bibi [怒了]查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100

凡利亚药品国际的公告

$凡利亚药品国际(VRX)$ 8-K - Current report Filed: 2018-12-14 AccNo: 0000885590-18-000074 Size: 56 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$凡利亚药品国际(VRX)$ 8-K - Current report Filed: 2018-11-27 AccNo: 0001193125-18-335247 Size: 1 MBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant...

$凡利亚药品国际(VRX)$ 8-K - Current report Filed: 2018-11-07 AccNo: 0001193125-18-321016 Size: 62 KBItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$凡利亚药品国际(VRX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-06 AccNo: 0000885590-18-000071 Size: 13 MB 网页链接

$凡利亚药品国际(VRX)$ 8-K - Current report Filed: 2018-10-31 AccNo: 0000885590-18-000063 Size: 62 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial...

$凡利亚药品国际(VRX)$ 8-K - Current report Filed: 2018-10-31 AccNo: 0000885590-18-000062 Size: 98 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

$凡利亚药品国际(VRX)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-08-10 AccNo: 0000885590-18-000056 Size: 97 KB 网页链接

$凡利亚药品国际(VRX)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-08-10 AccNo: 0000885590-18-000056 Size: 97 KB 网页链接

$凡利亚药品国际(VRX)$ 8-K - Current report Filed: 2018-08-10 AccNo: 0000885590-18-000055 Size: 23 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$凡利亚药品国际(VRX)$ 8-K - Current report Filed: 2018-08-10 AccNo: 0000885590-18-000055 Size: 23 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24